IMARC Group's report titled "Helicobacter Pylori Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032", offers a comprehensive analysis of the industry, which comprises insights on the global helicobacter pylori diagnostics market share. The global market size reached US$ 557.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 874.0 Million by 2032, exhibiting a growth rate (CAGR) of 5.13% during 2024-2032.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/helicobacter-pylori-diagnostics-market/requestsample
Factors Affecting the Growth of the Helicobacter Pylori Diagnostics Industry:
Helicobacter (H.) pylori infection is a leading cause of various gastric disorders, including gastritis, peptic ulcers, and gastric cancer. As the incidence of these disorders is rising, there is a greater need to accurately identify the underlying cause, which often involves testing for H. pylori infection. Moreover, early detection of H. pylori infection is crucial for effective management and prevention of complications, such as peptic ulcers and gastric cancer. As the incidence of gastric disorders is increasing, there is a greater emphasis on early diagnosis through H. pylori testing to initiate timely treatment and prevent disease progression.
Innovations in diagnostic technologies are leading to the development of tests with improved accuracy and sensitivity for detecting H. pylori infection. Newer methods, such as molecular diagnostic techniques like polymerase chain reaction (PCR) assays, offer higher sensitivity and specificity compared to traditional methods, leading to more reliable results and better patient outcomes. Furthermore, technological advancements are facilitating the development of non-invasive diagnostic tests for H. pylori, such as stool antigen tests and urea breath tests. These tests offer advantages over invasive procedures like endoscopy, including greater patient comfort, reduced risk of complications, and easier administration, thereby driving market adoption.
As healthcare expenditure is rising, individuals have greater access to healthcare services, including diagnostic testing for conditions like H. pylori infection. Increasing access to healthcare facilities and diagnostic services is leading to higher testing rates and greater demand for H. pylori diagnostics. In addition, higher healthcare expenditure often translates into investment in healthcare infrastructure, including the establishment of diagnostic laboratories and healthcare facilities equipped with advanced diagnostic technologies. This expansion of infrastructure enhances the availability and accessibility of H. pylori diagnostic tests.
Leading Companies Operating in the Global Helicobacter Pylori Diagnostics Industry: